J&J Says No Proof To Support Use Of Darunavir For COVID-19

Johnson and Johnson (JNJ) has revealed that there is no evidence to support the use of Darunavir for the treatment of COVID-19. There have been anecdotal, unsubstantiated reports claiming that Darunavir has antiviral effects against the novel coronavirus.

from RTT - Biotech https://ift.tt/2Wl0SUL
via IFTTT